AI-generated summary
The authors reviewed randomized clinical trials of bright light therapy for depressive symptoms linked to premenstrual dysphoric disorder. Four crossover trials with a total of 55 participants met inclusion criteria, and the pooled effect from three higher quality trials was small and not statistically clear. The authors conclude the evidence is too uncertain to either recommend or reject the therapy.
- Participants
- 55
- Studies included
- 4
- Who or what was studied
- Women with premenstrual dysphoric disorder (participants in four crossover randomized trials)
- Limits stated in the abstract
- Trials were small with wide confidence limits, had methodologic limitations, and one trial was fully unblinded.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Depression, Systematic review, Meta-analysis, Effect size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.